123 related articles for article (PubMed ID: 34491226)
21. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.
Gadoev J; Asadov D; Tillashaykhov M; Tayler-Smith K; Isaakidis P; Dadu A; de Colombani P; Gudmund Hinderaker S; Parpieva N; Ulmasova D; Jalolov A; Hamraev A; Ali E; Boom Mv; Hammerich A; Gozalov O; Dara M
PLoS One; 2015; 10(6):e0128907. PubMed ID: 26075615
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
Chaves-Torres NM; Fadul S; Patiño J; Netto E
PLoS One; 2021; 16(4):e0249565. PubMed ID: 33852619
[TBL] [Abstract][Full Text] [Related]
23. Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.
Tobón Á; Rueda J; Cáceres DH; Mejía GI; Zapata EM; Montes F; Ospina A; Fadul S; Paniagua L; Robledo J
Biomedica; 2020 Dec; 40(4):616-625. PubMed ID: 33275341
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for unsuccessful tuberculosis treatment outcomes in children.
Hamid M; Brooks MB; Madhani F; Ali H; Naseer MJ; ; Becerra M; Amanullah F
PLoS One; 2019; 14(9):e0222776. PubMed ID: 31553758
[TBL] [Abstract][Full Text] [Related]
25. The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.
Adamu AL; Aliyu MH; Galadanci NA; Musa BM; Lawan UM; Bashir U; Abubakar I
Int J Equity Health; 2018 Jan; 17(1):4. PubMed ID: 29310659
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.
Karo B; Hauer B; Hollo V; van der Werf MJ; Fiebig L; Haas W
Euro Surveill; 2015; 20(49):. PubMed ID: 26676247
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Adane K; Spigt M; Dinant GJ
BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 pandemic and other factors associated with unfavorable tuberculosis treatment outcomes-Almaty, Kazakhstan, 2018-2021.
Gabdullina M; Maes EF; Horth RZ; Dzhazybekova P; Amanova GN; Zikriyarova S; Nabirova DA
Front Public Health; 2023; 11():1247661. PubMed ID: 37808989
[TBL] [Abstract][Full Text] [Related]
29. Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis.
Prado TN; Rajan JV; Miranda AE; Dias ED; Cosme LB; Possuelo LG; Sanchez MN; Golub JE; Riley LW; Maciel EL
Braz J Infect Dis; 2017; 21(2):162-170. PubMed ID: 27936379
[TBL] [Abstract][Full Text] [Related]
30. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register.
Schnippel K; Shearer K; Evans D; Berhanu R; Dlamini S; Ndjeka N
Int J Infect Dis; 2015 Oct; 39():89-94. PubMed ID: 26358856
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010-2015.
Wobudeya E; Jaganath D; Sekadde MP; Nsangi B; Haq H; Cattamanchi A
BMC Public Health; 2019 Apr; 19(1):446. PubMed ID: 31035984
[TBL] [Abstract][Full Text] [Related]
32. Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria.
Oshi SN; Alobu I; Ukwaja KN; Oshi DC
Epidemiol Infect; 2015 Apr; 143(5):932-42. PubMed ID: 25355040
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
Ejeh FE; Undiandeye A; Okon K; Moshood KH
Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.
Ahmad T; ; Khan M; Khan MM; Ejeta E; Karami M; Ohia C
Int J Mycobacteriol; 2017; 6(4):360-364. PubMed ID: 29171450
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
[TBL] [Abstract][Full Text] [Related]
36. Mortality among tuberculosis patients in Saudi Arabia (2001-2010).
Abouzeid MS; Al RF; Memish ZA
Ann Saudi Med; 2013; 33(3):247-52. PubMed ID: 23793426
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.
Thekkur P; Kumar AN; Chinnakali P; Selvaraju S; Bairy R; Singh AR; Nirgude A; Selvaraj K; Venugopal V; Shastri S
Glob Health Action; 2019; 12(1):1568826. PubMed ID: 30712507
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of mortality caused by tuberculosis in Medellín, Colombia, 2012].
Villa L; Trompa IM; Montes FN; Gómez JG; Restrepo CA
Biomedica; 2014; 34(3):425-32. PubMed ID: 25504129
[TBL] [Abstract][Full Text] [Related]
39. Mortality of tuberculosis patients during treatment in Israel, 2000-2010.
Shuldiner J; Leventhal A; Chemtob D; Mor Z
Int J Tuberc Lung Dis; 2014 Jul; 18(7):818-23. PubMed ID: 24902558
[TBL] [Abstract][Full Text] [Related]
40. Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
Osman M; Meehan SA; von Delft A; Du Preez K; Dunbar R; Marx FM; Boulle A; Welte A; Naidoo P; Hesseling AC
PLoS One; 2021; 16(6):e0252084. PubMed ID: 34125843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
